CN114478375A - Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative - Google Patents

Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative Download PDF

Info

Publication number
CN114478375A
CN114478375A CN202210169835.4A CN202210169835A CN114478375A CN 114478375 A CN114478375 A CN 114478375A CN 202210169835 A CN202210169835 A CN 202210169835A CN 114478375 A CN114478375 A CN 114478375A
Authority
CN
China
Prior art keywords
alkenylquinolin
derivative
nitrobenzaldehyde
reaction
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202210169835.4A
Other languages
Chinese (zh)
Other versions
CN114478375B (en
Inventor
祁昕欣
刘建利
王尉
吴小锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Sci Tech University ZSTU
Original Assignee
Zhejiang Sci Tech University ZSTU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Sci Tech University ZSTU filed Critical Zhejiang Sci Tech University ZSTU
Priority to CN202210169835.4A priority Critical patent/CN114478375B/en
Publication of CN114478375A publication Critical patent/CN114478375A/en
Application granted granted Critical
Publication of CN114478375B publication Critical patent/CN114478375B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a preparation method of a 3-alkenyl quinoline-2 (1H) ketone derivative, which comprises the following steps: reacting palladium acetate, tri (3-methoxyphenyl) phosphine, molybdenum carbonyl, cesium carbonate, tetrabutylammonium iodide, o-nitrobenzaldehyde and allyl aryl ether at 100 ℃ for 30 hours, and after the reaction is completed, carrying out post-treatment to obtain the 3-alkenyl quinoline-2 (1H) ketone derivative. The preparation method uses o-nitrobenzaldehyde as a nitrogen source and a formyl source, is simple to operate, has cheap and easily-obtained reaction starting raw materials, wide substrate functional group tolerance range and high reaction efficiency. Can synthesize a plurality of 3-alkenyl quinoline-2 (1H) ketone derivatives according to actual needs, is convenient to operate and widens the practicability of the method.

Description

Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a preparation method of a 3-alkenyl quinoline-2 (1H) ketone derivative.
Background
The nitrogen heterocyclic compound is widely existed in various natural products and bioactive compounds, particularly quinoline-2 (1H) -ketone and derivatives thereof as special construction units, show various pharmaceutical activities, and are often used as antibiotics, antitumor drugs, antiplatelet drugs, endothelin receptor antagonists and angiotensin II receptor antagonists (J.Med.chem.1997,40, 754-765). Some quinolin-2 (1H) -ones, such as nybomycin and deoxybomycin, have become effective antibacterial agents. In addition, the quinolin-2 (1H) one derivatives are useful as intermediates in organic synthesis and play a very important role (J.Am.chem.Soc.2002,124, 7982-7990). Therefore, the synthesis of quinoline-2 (1H) ketone derivatives attracts the attention of chemists, and the search for new methods for preparing such important nitrogen heterocyclic compounds has been a long-term goal of synthesis and medicinal chemistry.
Figure BDA0003517166240000011
Transition metal catalyzed carbonylation is one of the most economical and direct methods for the synthesis of carbonyl-containing compounds (Chem 2019,5, 526-. Since Heck and colleagues pioneered work in 1974, palladium-catalyzed carbonylation reactions have attracted extensive interest in both industrial and academic fields. Aryl and vinyl halides (or pseudohalides) have also gained intensive application and research in carbonylation reactions. In addition, allyl compounds, as a very challenging class of electrophiles, can be directly converted into β, γ -unsaturated carboxylic compounds. However, research on carbonylation reactions in which such compounds participate has been limited, and most carbonylation reactions use allyl chloride, acetate, carbonate, and phosphate as electrophiles. Allyl ethers are of much less interest than these allyl derivatives and remain a challenging target. Based on the characteristics of natural property, low toxicity, easy operation and the like of allyl ether, exploring a carbonylation reaction taking allyl ether as an electrophilic reagent is one of the hot spots which people pay attention to.
Based on this, we developed a palladium-catalyzed reductive aminocarbonylation of o-nitrobenzaldehyde and allyl aryl ether to 3-alkenylquinolin-2 (1H) one derivatives. The reaction takes o-nitrobenzaldehyde as a nitrogen source and a formyl source to synthesize various 3-alkenyl quinoline-2 (1H) ketone derivatives with good to excellent yield. Notably, this is the first example of the reaction of an allyl aryl ether involved in the aminocarbonylation of a 3-alkenylquinolin-2 (1H) one derivative.
Disclosure of Invention
The invention provides a preparation method of a 3-alkenyl quinoline-2 (1H) ketone derivative, which has the advantages of simple steps, cheap and easily-obtained reaction raw materials, compatibility with various functional groups and good reaction applicability, and provides a new direction for the synthesis of the 3-alkenyl quinoline-2 (1H) ketone derivative by taking o-nitrobenzaldehyde as a nitrogen source and a formyl source.
A preparation method of a 3-alkenyl quinoline-2 (1H) ketone derivative comprises the following steps: reacting a palladium catalyst, tri (3-methoxyphenyl) phosphine, molybdenum carbonyl, cesium carbonate, an additive, o-nitrobenzaldehyde and allyl aryl ether at 90-110 ℃ for 28-32 hours, and after the reaction is completed, carrying out post-treatment to obtain the 3-alkenyl quinoline-2 (1H) ketone derivative;
the structure of the o-nitrobenzaldehyde is shown as the formula (II):
Figure BDA0003517166240000021
the structure of the allyl aryl ether is shown as the formula (III):
Figure BDA0003517166240000022
the structure of the 3-alkenyl quinoline-2 (1H) ketone derivative is shown as the formula (I):
Figure BDA0003517166240000023
in formulae (I) to (III), R1,R2Independently is H or methyl; r3Is H, C1~C4Alkyl, substituted or unsubstituted aryl or heterocyclic; r4Is H, methoxy or halogen;
the substituent on the aryl is C1~C4Alkyl, methoxy, trifluoromethyl or halogen;
the molar ratio of the palladium catalyst, the tri (3-methoxyphenyl) phosphine, the cesium carbonate and the tetrabutylammonium iodide is 0.1:0.2:3: 3;
R4is meta.
The reaction formula is as follows:
Figure BDA0003517166240000031
in the present invention, the optional post-processing procedure includes: filtering, mixing the sample with silica gel, and finally purifying by column chromatography to obtain the corresponding 3-alkenyl quinoline-2 (1H) ketone derivative, wherein the purification by column chromatography is a technical means commonly used in the field.
Preferably, R4Is H, methoxy, F or Cl, in this case, the o-nitrobenzaldehyde is easily obtained, and the reaction yield is high.
Preferably, R1Is H or methyl; r2Is H or methyl; r3Is H, methyl, propyl, tert-butyl, 4-tert-butylphenyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, 4-fluorophenyl, 4-chlorophenyl, 3-furyl, in which case the allyl aryl ether is readily available and the reaction yields are high.
The o-nitrobenzaldehyde and allyl aryl ether used to prepare the 3-alkenylquinolin-2 (1H) one derivatives are relatively inexpensive and widely available in nature, and preferably, the o-nitrobenzaldehyde: allyl aryl ether: a palladium catalyst is 1.2-1.5: 1: 0.05-0.1; as a further preference, the molar amount of o-nitrobenzaldehyde: allyl aryl ether: palladium catalyst 1.5:1: 0.1.
Preferably, the reaction time is 30 hours, and if the reaction time is too long, the reaction cost is increased, and on the contrary, it is difficult to ensure the completion of the reaction.
Preferably, the reaction is carried out in acetonitrile, the amount of acetonitrile used is sufficient to dissolve the starting material, and the amount of acetonitrile used is about 1 to 2mL for 0.2mmol of allyl aryl ether.
Preferably, the palladium catalyst is palladium acetate, which is relatively inexpensive among a large number of palladium catalysts, and the reaction efficiency is high when palladium acetate is used as the catalyst.
As a further preference, the 3-alkenyl quinolin-2 (1H) one derivative is one of the compounds represented by formula (I-1) to formula (I-5):
Figure BDA0003517166240000041
in the above preparation method, the o-nitrobenzaldehyde, allyl aryl ether, molybdenum carbonyl, palladium acetate, tris (3-methoxyphenyl) phosphine, tetrabutylammonium iodide and cesium carbonate are generally commercially available products, and can be conveniently obtained from the market.
Compared with the prior art, the invention has the beneficial effects that: the o-nitrobenzaldehyde is used as a nitrogen source and a formyl source, the preparation method is simple, the operation is easy, the post-treatment is simple and convenient, the reaction starting material is cheap and easy to obtain, the tolerance range of a substrate functional group is wide, and the reaction efficiency is high. Can synthesize various 3-alkenyl quinoline-2 (1H) ketone derivatives according to actual needs, and has strong practicability.
Detailed Description
The invention is further described with reference to specific examples.
Examples 1 to 15
Adding palladium acetate, tri (3-methoxyphenyl) phosphine, molybdenum carbonyl, cesium carbonate, tetrabutylammonium iodide, o-nitrobenzaldehyde (II) and allyl aryl ether (III) into a 15mL sealed tube according to the raw material ratio in Table 1, then adding acetonitrile (1mL), uniformly mixing and stirring, reacting according to the reaction conditions in Table 2, filtering after the reaction is finished, stirring a sample with silica gel, and purifying by column chromatography to obtain a corresponding 3-alkenyl quinoline-2 (1H) ketone derivative (I), wherein the reaction process is shown as the following formula:
Figure BDA0003517166240000051
TABLE 1 raw material addition amounts of examples 1 to 15
Figure BDA0003517166240000052
TABLE 2
Figure BDA0003517166240000053
Figure BDA0003517166240000061
In tables 1 and 2, T is the reaction temperature, T is the reaction time, Me is methyl, Pr is propyl, T-Bu is methyl, OMe is methoxy, CF is3Is trifluoromethyl.
Structure confirmation data of the compounds prepared in examples 1 to 5:
nuclear magnetic resonance of 3-alkenylquinolin-2 (1H) one derivative (I-1) prepared in example 1 (1)1H NMR and13c NMR) the data were:
Figure BDA0003517166240000062
1H NMR(400MHz,DMSO-d6)δ11.73(s,1H),7.78(s,1H),7.61–7.54(m,1H),7.39–7.33(m,1H),7.23–7.19(m,1H),7.11–7.01(m,1H),5.88–5.82(m,1H),5.14(s,1H),2.23–1.92(s,3H).
13C NMR(101MHz,DMSO-d6)δ161.0,140.1,138.1,136.0,132.0,130.1,128.0,121.8,119.2,117.5,114.5,22.4.
nuclear magnetic resonance of 3-alkenylquinolin-2 (1H) one derivative (I-2) prepared in example 2 ((I-2))1H NMR and13c NMR) the data were:
Figure BDA0003517166240000063
1H NMR(400MHz,DMSO-d6)δ11.79(s,1H),7.94(s,1H),7.64–7.57(m,1H),7.45–7.37(m,1H),7.28–7.22(m,1H),7.18–7.09(m,1H),6.75–6.61(m,1H),6.53–6.44(m,1H),2.21–2.10(m,2H),1.51–1.39(m,2H),0.95–0.83(m,3H).
13C NMR(101MHz,DMSO-d6)δ161.2,137.6,134.0,133.7,129.6,128.5,127.6,124.6,121.9,119.5,114.7,35.2,22.0,13.7.
nuclear magnetic resonance of 3-alkenylquinolin-2 (1H) one derivative (I-3) prepared in example 3 (II-3)1H NMR and13c NMR) the data were:
Figure BDA0003517166240000071
1H NMR(400MHz,DMSO-d6)δ11.89(s,1H),8.13(s,1H),7.66–7.63(m,1H),7.62(s,1H),7.43(m,3H),7.27(m,1H),7.22(m,1H),7.17–7.13(m,3H),2.27(s,3H).
13C NMR(101MHz,DMSO-d6)δ161.2,137.7,137.4,134.8,134.5,131.1,129.9,129.5,128.5,128.3,127.8,126.5,122.5,122.1,119.6,114.8,20.9.
nuclear magnetic resonance of 3-alkenylquinolin-2 (1H) one derivative (I-4) prepared in example 4 (II-1H)1H NMR and13c NMR) the data were:
Figure BDA0003517166240000072
1H NMR(400MHz,DMSO-d6)δ11.91(s,1H),8.04(s,1H),7.88(s,1H),7.71–7.60(m,3H),7.49–7.39(m,1H),7.31–7.23(m,1H),7.20–7.11(m,1H),7.02–6.93(m,1H),6.87–6.84(m,1H).
13C NMR(101MHz,DMSO-d6)δ161.2,144.5,142.2,137.6,134.8,129.9,128.2,127.7,124.9,123.4,122.0,121.9,119.6,114.8,107.4.
nuclear magnetic resonance of 3-alkenylquinolin-2 (1H) one derivative (I-5) prepared in example 5 ((I-5))1H NMR and13c NMR) the data were:
Figure BDA0003517166240000073
1H NMR(400 MHz,CDCl3)δ12.25(s,1H),7.39–7.32(m,1H),7.25(m,2H),5.88(m,1H),5.37(m,1H),2.24(s,3H).
13C NMR(101 MHz,CDCl3)δ163.1,158.2(d,J=241.7 Hz),140.4,135.9(d,J=3.2 Hz),134.5(d,J=22.0 Hz),120.7(d,J=9.3 Hz),118.7,118.6,118.5,117.1(d,J=8.3 Hz),112.5(d,J=22.7 Hz),22.6。

Claims (9)

1. a method for preparing a 3-alkenylquinolin-2 (1H) one derivative, comprising the steps of: reacting a palladium catalyst, a ligand, molybdenum carbonyl, alkali, an additive, o-nitrobenzaldehyde and allyl aryl ether at 90-110 ℃ for 28-32 hours, and after the reaction is completed, carrying out post-treatment to obtain the 3-alkenyl quinoline-2 (1H) ketone derivative;
the structure of the o-nitrobenzaldehyde is shown as the formula (II):
Figure FDA0003517166230000011
the structure of the allyl aryl ether is shown as the formula (III):
Figure FDA0003517166230000012
the structure of the 3-alkenyl quinoline-2 (1H) ketone derivative is shown as the formula (I):
Figure FDA0003517166230000013
in the formulae (I) to (III), R1,R2Independently is H or methyl; r3Is H, C1~C4Alkyl, substituted or unsubstituted aryl or heterocyclic; r4Is H, methoxy or halogen;
the substituents on the aryl areC1~C4Alkyl, methoxy, trifluoromethyl or halogen.
2. The method for preparing 3-alkenylquinolin-2 (1H) one derivative according to claim 1, wherein R is1Is H or methyl; r2Is H or methyl; r3Is H, methyl, propyl, tert-butyl, 4-tert-butylphenyl, 4-methoxyphenyl, 4-trifluoromethylphenyl, 4-fluorophenyl, 4-chlorophenyl, 3-furyl; r4Is H, methoxy, F or Cl.
3. The process for producing a 3-alkenylquinolin-2 (1H) one derivative according to claim 1, wherein the molar ratio of o-nitrobenzaldehyde: allyl aryl ether: molybdenum carbonyl: palladium catalyst: ligand: alkali: the additive is 1.2-1.5: 1: 1.2-1.5: 0.05-0.1: 0.1-0.2: 3-4.
4. The method for producing a 3-alkenylquinolin-2 (1H) one derivative according to claim 1, wherein the reaction is carried out using acetonitrile as a solvent.
5. The method of claim 1, wherein the palladium catalyst is palladium acetate.
6. The process for preparing a 3-alkenylquinolin-2 (1H) one derivative according to claim 1, wherein the ligand is tris (3-methoxyphenyl) phosphine.
7. The process for preparing a 3-alkenylquinolin-2 (1H) one derivative according to claim 1, wherein the base is cesium carbonate.
8. The method of claim 1, wherein the additive is tetrabutylammonium iodide.
9. The method for preparing a 3-alkenylquinolin-2 (1H) one derivative according to claim 1, wherein the 3-alkenylquinolin-2 (1H) one derivative is one of the compounds represented by formula (I-1) to formula (I-5):
Figure FDA0003517166230000021
CN202210169835.4A 2022-02-23 2022-02-23 Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative Active CN114478375B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210169835.4A CN114478375B (en) 2022-02-23 2022-02-23 Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210169835.4A CN114478375B (en) 2022-02-23 2022-02-23 Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative

Publications (2)

Publication Number Publication Date
CN114478375A true CN114478375A (en) 2022-05-13
CN114478375B CN114478375B (en) 2023-08-18

Family

ID=81484362

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210169835.4A Active CN114478375B (en) 2022-02-23 2022-02-23 Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative

Country Status (1)

Country Link
CN (1) CN114478375B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115286556A (en) * 2022-09-02 2022-11-04 浙江理工大学 Preparation method of ester compound containing indolone or isoquinoline-1, 3-diketone structure
CN115403520A (en) * 2022-08-30 2022-11-29 浙江理工大学 Preparation method of quinoline-2 (1H) -ketone derivative

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112125856A (en) * 2020-09-08 2020-12-25 浙江理工大学 Preparation method of 2-trifluoromethyl substituted quinazolinone derivative
CN112480015A (en) * 2020-12-11 2021-03-12 浙江理工大学 Method for synthesizing 2-trifluoromethyl substituted quinazolinone by multi-component one-pot method
CN113045489A (en) * 2021-03-09 2021-06-29 浙江理工大学 Preparation method of 3-arylquinoline-2 (1H) ketone derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112125856A (en) * 2020-09-08 2020-12-25 浙江理工大学 Preparation method of 2-trifluoromethyl substituted quinazolinone derivative
CN112480015A (en) * 2020-12-11 2021-03-12 浙江理工大学 Method for synthesizing 2-trifluoromethyl substituted quinazolinone by multi-component one-pot method
CN113045489A (en) * 2021-03-09 2021-06-29 浙江理工大学 Preparation method of 3-arylquinoline-2 (1H) ketone derivative

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JIAN-LI LIU,等: "Palladium-Catalyzed Reductive Aminocarbonylation of o‑Iodophenol-Derived Allyl Ethers with o‑Nitrobenzaldehydes to 3‑Alkenylquinolin-2(1H)‑ones", 《ORG. LETT.》 *
PHILIPP FACKLER,等: "Enantio- and Regioselective Epoxidation of Olefinic Double Bonds in Quinolones, Pyridones, and Amides Catalyzed by a Ruthenium Porphyrin Catalyst with a Hydrogen Bonding Site", 《J. AM. CHEM. SOC.》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115403520A (en) * 2022-08-30 2022-11-29 浙江理工大学 Preparation method of quinoline-2 (1H) -ketone derivative
CN115403520B (en) * 2022-08-30 2023-12-19 浙江理工大学 Preparation method of quinoline-2 (1H) -ketone derivative
CN115286556A (en) * 2022-09-02 2022-11-04 浙江理工大学 Preparation method of ester compound containing indolone or isoquinoline-1, 3-diketone structure
CN115286556B (en) * 2022-09-02 2023-10-03 浙江理工大学 Preparation method of ester compound containing indolone or isoquinoline-1, 3-dione structure

Also Published As

Publication number Publication date
CN114478375B (en) 2023-08-18

Similar Documents

Publication Publication Date Title
CN113045489B (en) Preparation method of 3-arylquinoline-2 (1H) ketone derivative
CN114478375B (en) Preparation method of 3-alkenyl quinoline-2 (1H) ketone derivative
CN111675662B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound
CN113105402B (en) Preparation method of 3,4, 5-trisubstituted 1,2, 4-triazole compound
CN113121462B (en) Preparation method of 5-trifluoromethyl substituted 1,2,3-triazole compound
CN111423381A (en) Preparation method of 2-trifluoromethyl substituted imidazole compound
CN112125856A (en) Preparation method of 2-trifluoromethyl substituted quinazolinone derivative
CN112321593B (en) Preparation method of indolo [1,2-a ] quinazoline-6 (5H) -ketone compound
CN113307778A (en) Preparation method of 3-trifluoromethyl substituted 1,2, 4-triazole compound
CN114539198A (en) Preparation method of amide compound containing (iso) chroman structure
CN106083716B (en) A kind of preparation method of 3- aryl isoquinolines compound
CN112480015B (en) Method for synthesizing 2-trifluoromethyl substituted quinazolinone by multi-component one-pot method
CN113045503B (en) Preparation method of 2-trifluoromethyl substituted quinazolinone compound and application of compound in synthesis of drug molecules
CN115260080B (en) Preparation method of indole-3-formamide compound
CN113880781B (en) Method for synthesizing 3-trifluoromethyl substituted 1,2, 4-triazole compound by taking glucose as carbon source
CN115772157A (en) Preparation method of 2-alkoxy indole compound
CN115403520B (en) Preparation method of quinoline-2 (1H) -ketone derivative
CN107936025A (en) A kind of preparation method of anti-2,3 dibasic bicyclic pyrazole alkanone compound of chirality
CN110357879B (en) Preparation method of C-3 benzyl indolizine compound
CN113735826B (en) Preparation method of 3-benzylidene-2, 3-dihydroquinolone compound
CN110305157B (en) Conjugated eneyne amide derivatives, and preparation method and application thereof
CN115286628B (en) Preparation method of indolo [2,1a ] isoquinoline compound
CN112239456B (en) Preparation method of substituted 2, 3-dihydroquinolone compound
CN115260188B (en) Preparation method of tetrahydro-beta-carboline ketone compound
CN116640146A (en) Preparation method of trifluoromethyl substituted chromone quinoline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant